Choosing the Right Pacing Mode in Heart Failure - The CHOICE Trial (CHOICE)

July 7, 2017 updated by: AChoy, University of Dundee

CHOosing the rIght paCing Mode in Heart failurE : Should Heart Failure Patients With Bradycardia Receive Biventricular Pacemakers Rather Than Conventional Pacemakers?

The aim of the study is to see if biventricular pacemakers offer any advantage over conventional pacemakers in patients with heart failure who require pacemakers. The endpoints will be the 6 minute walking distance along with markers of cardiovascular function.

The investigators' hypothesis is that biventricular pacing is preferable to conventional pacing in these heart failure patients.

Study Overview

Status

Completed

Conditions

Intervention / Treatment

Study Type

Interventional

Enrollment (Actual)

22

Phase

  • Not Applicable

Contacts and Locations

This section provides the contact details for those conducting the study, and information on where this study is being conducted.

Study Locations

  • United Kingdom
    • UK
      • Dundee, UK, United Kingdom, DD1 9SY
        • Ninewells Hospital & Medical School

Participation Criteria

Researchers look for people who fit a certain description, called eligibility criteria. Some examples of these criteria are a person's general health condition or prior treatments.

Eligibility Criteria

Ages Eligible for Study

18 years and older (Adult, Older Adult)

Accepts Healthy Volunteers

No

Genders Eligible for Study

All

Description

Inclusion Criteria:

  1. Left ventricular systolic dysfunction.
  2. Atrio-ventricular node disease.
  3. Anticipated to be more than 40% paced, (including patients in permanent atrial fibrillation).
  4. Ability to walk independently (walking aid permitted).

Exclusion Criteria:

  1. Patients meeting criteria for CRT by current guidelines will be excluded.
  2. Life expectancy less than12 months.
  3. Inability to walk independently.
  4. Patients not likely to be compliant with follow-up.
  5. Bradyarrhythmia due with sino-atrial disease only.

Study Plan

This section provides details of the study plan, including how the study is designed and what the study is measuring.

How is the study designed?

Design Details

  • Primary Purpose: Treatment
  • Allocation: Randomized
  • Interventional Model: Crossover Assignment
  • Masking: Quadruple

Arms and Interventions

Participant Group / Arm
Intervention / Treatment
Experimental: 1
Biventricular Pacing
Device: Bi Ventricular Pacing
Active Comparator: 2
Right Ventricular Pacing
Device: Right Ventricular Pacing

What is the study measuring?

Primary Outcome Measures

Outcome Measure
Time Frame
6 minute hall walk test
Time Frame: Baseline, 3, 6, 9 and 12 months
Baseline, 3, 6, 9 and 12 months

Secondary Outcome Measures

Outcome Measure
Time Frame
Endothelial Function
Time Frame: Baseline, 3, 6, 9 and 12 months
Baseline, 3, 6, 9 and 12 months
Cardiac Output
Time Frame: Baseline, 3, 6, 9 and 12 months
Baseline, 3, 6, 9 and 12 months

Collaborators and Investigators

This is where you will find people and organizations involved with this study.

Sponsor

University of Dundee

Collaborators

Abbott Medical Devices
Chest, Heart and Stroke Association Scotland

Study record dates

These dates track the progress of study record and summary results submissions to ClinicalTrials.gov. Study records and reported results are reviewed by the National Library of Medicine (NLM) to make sure they meet specific quality control standards before being posted on the public website.

Study Major Dates

Study Start

September 1, 2009

Primary Completion (Actual)

September 1, 2010

Study Completion (Actual)

January 1, 2011

Study Registration Dates

First Submitted

March 31, 2009

First Submitted That Met QC Criteria

March 31, 2009

First Posted (Estimate)

April 3, 2009

Study Record Updates

Last Update Posted (Actual)

July 11, 2017

Last Update Submitted That Met QC Criteria

July 7, 2017

Last Verified

July 1, 2017

More Information

Terms related to this study

Keywords

Additional Relevant MeSH Terms

Other Study ID Numbers

  • ELD001

This information was retrieved directly from the website clinicaltrials.gov without any changes. If you have any requests to change, remove or update your study details, please contact register@clinicaltrials.gov. As soon as a change is implemented on clinicaltrials.gov, this will be updated automatically on our website as well.

Subscribe